Clinical use of procalcitonin in the patient with suspected sepsis

June 19, 2018

This webinar will review the definition of sepsis, and the use of biomarkers and their suitability as a point-of-care test, mainly focusing on procalcitonin. The webinar is presented in Portuguese.

Playback

Utilidade clínica da procalcitonina no paciente com suspeita de sepsis

Descrição

Dra. Carla Mimoso Santos

Responsável pelo PAPA- Programa de Apoio à Prerscrição Antimicrobiana do GCL-PPCIRA- Grupo de Coordenação Local do Programa de Prevenção e Controlo de Infeções e da Resistência aos Antimicrobianos  do C.H. Lisboa Norte (Hospital Santa María).

Dr. Hugo Ferreira

Cuidados Intensivos Cirurgia Cardiotorácica. do C.H. Lisboa Norte (Hospital Santa María)

O conteúdo visa analisar o valor aportado pelo diagnóstico e prognóstico com recurso à procalcitonina em sintomas de sepsis, e a sua utilidade na terapia a aplicar ao paciente em comparação com outros métodos, como a hemocultura ou a PCR. Também enfocar-se-ão as temáticas do máximo tempo de resposta (TAT) aceitável para os resultados e do intervalo de medição. Em suma discutir-se-á a real necessidade da PCT como teste POCT.

 

Cookies are used on this website

Use of cookies
Don't show this message again
Confirm your account with Radiometer

Please enter a valid email

CONTINUE
By submitting your e-mail you agree to the data policy notice
Radiometer is using Microsoft Azure Active Directory to authenticate customer access. If you are already registered you will be taken to Microsoft AD to sign in using your Microsoft AD credentials.
You are already registered
SIGN IN
Radiometer is using Microsoft Azure AD to authenticate customer access. If you are already registered you will be taken to AZURE to sign in using your AZURE credentials.
Thank you

We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.

CLOSE BANNER
Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

It seems that your e-mail is not registered with us

TRY AGAIN CONTINUE
Radiometer is using Microsoft Azure AD to authenticate customer access. If your e-mail is not registered with us please click CONTINUE and we will guide you through the sign-in process.
We have previously sent an invitation by e-mail

Please click "Get started" in the e-mail to complete the registration process

RESEND E-MAIL
Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

We were not able to process your request due to a communication error

TRY AGAIN
Sorry

It seems this account has not been given access to the portal

Continue

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

       
  • Allow the use of existing Active Directory credentials
  • Single-sign on experience
  • Use same credentials to access future services

Request access

You will receive an invitation to access our services via e-mail when your request has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, an account will be created for you automatically.